AstraZeneca's drug combo helps lung cancer patients live longer in late-stage study
- Posted on September 8, 2026
- By Bing News
- 0 Views
- 1 min read
In brief
Generating AI summary…
AstraZeneca's drug combo helps lung cancer patients live longer in late-stage study
Sept 8 (Reuters) - AstraZeneca said on Tuesday its cancer drug, Imfinzi, combined with Amgen's targeted immunotherapy, Imdelltra, significantly improved overall survival of extensive-stage small-cell lung cancer patients in a late-stage trial. Here are some details: • The trial tested the combination as a maintenance treatment against Imfinzi alone in patients whose disease had not progressed
